Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2151-2160 of 9364

Page
per page
  1. Insulin (human) recombinant expressed in yeast
    B7407 Insulin (human) recombinant expressed in yeast
    Target: Insulin Receptors
    Summary: Endogenous insulin receptor agonist
      ≥58.1 mg/mL
  2. [D-Trp34]-Neuropeptide Y
    B7408 [D-Trp34]-Neuropeptide Y
    Summary: neuropeptide Y (NPY) Y5 receptor agonist
  3. Astemizole
    B7409 Astemizole
    Summary: anti-histamine compound, potent
      insoluble in H2O; ≥11.46 mg/mL
  4. Cyclosomatostatin
    B7411 Cyclosomatostatin
     1 Citation
    Summary: somatostatin receptor antagonist
      Soluble to 1 mg/mL
  5. RGDS peptide
    B7412 RGDS peptide
    Summary: Integrin binding sequence that inhibits integrin receptor function
      ≥21.65 mg/mL
  6. NPE-caged-proton
    B7416 NPE-caged-proton
    Summary: Generates rapid acidifications down to pH 2
      <26.92 mg/mL
  7. Tunicamycin
    B7417 Tunicamycin
     15 Citation
    Summary: antibiotic,inhibits GlcNAc phosphotransferase (GPT)
      ≥25 mg/mL
  8. PD 173212
    B7424 PD 173212
    Summary: N-type voltage-gated calcium channel blocker
      Soluble in DMSO
  9. Margatoxin
    B7428 Margatoxin
    Summary: KV1.3 channel blocker
      Soluble to 0.50 mg/mL
  10. Bretazenil
    B7430 Bretazenil
    Summary: GABAA benzodiazepine site partial agonist
      <41.83 mg/mL

Items 2151-2160 of 9364

Page
per page